RanBP9 overexpression reduces dendritic arbor and spine density

Area of Science:

• Neuroscience
• Molecular Biology
• Alzheimer's Disease Research

Background:

• RanBP9 is a scaffolding protein influencing intracellular signaling.
• Previous studies linked RanBP9 to enhanced amyloid-beta (Aβ) generation and synaptic protein loss in Alzheimer's disease (AD) models.
• Spinophilin levels, a dendritic spine marker, inversely correlate with RanBP9 in AD brains.

Purpose of the Study:

• To investigate the impact of RanBP9 on neuronal structure, specifically dendritic arborization and spine density.
• To examine the role of RanBP9 in regulating key synaptic proteins, including cofilin and spinophilin.
• To establish a mechanistic link between RanBP9, synaptic integrity, and cognitive deficits.

Main Methods:

• Analysis of dendritic intersections and spine density in cortical and hippocampal neurons of RanBP9 transgenic mice at 6 and 12 months.
• Quantification of phosphorylated cofilin and spinophilin levels in synaptosomes isolated from RanBP9 transgenic and wild-type mice.
• Correlation analysis between dendritic structure, protein levels, and cognitive function.

Main Results:

• RanBP9 transgenic mice exhibited reduced dendritic intersections and spine density in the cortex and hippocampus at 12 months but not at 6 months.
• Significant decreases in phosphorylated cofilin (26% cortical, 36% hippocampal) and spinophilin (20% cortical) were observed in RanBP9 transgenic mice at 12 months.
• Dendritic arborization and spine density directly correlated with phosphorylated cofilin levels.

Conclusions:

• RanBP9 significantly impairs dendritic structure and spine density in a time-dependent manner.
• Reduced levels of phosphorylated cofilin and spinophilin contribute to synaptic protein loss mediated by RanBP9.
• These findings provide a physical basis for RanBP9-induced synaptic deficits and associated cognitive impairments in Alzheimer's disease.